Announcement PDF 23 February 2024 The Manager Company Announcements Australian Stock Exchange Limited Via Electronic Lodgement Dear Sir/Madam PHARMAUST LIMITED (ASX: PAA & PAAOA) - SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001 The Company gives this notice pursuant to section 708A(5)(e) of the Corporations Act 2001 (Cth) (“Act”). The Company has issued 730,000 fully paid ordinary shares in the capital of the Company as per the Appendix 2A's lodged with the ASX today. The Company advises that the securities were issued without disclosure to investors under Part 6D.2 of the Act. The Company, as at the date of this notice, has complied with: (a) the provisions of Chapter 2M of the Act as they apply to the Company; and (b) section 674 of the Act. As at the date of this notice there is no information that is excluded information for the purposes of sections 708A(7) and (8) of the Act. This announcement is authorised by Sam Wright on behalf of the Board of Directors. Yours sincerely, Sam Wright Finance Director PharmAust Limited ABN 35 094 006 023. Suite 116, 1 Kyle Way, Claremont, Western Australia Tel: 08 9202 6814 Fax: 08 9467 6111 www.pharmaust.com